| Just Other Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Finance > Bankruptcy > Bankruptcy Instead of Debtor's Prison |
|
Just Other Articles - Bankruptcy Instead of Debtor's Prison
Bankruptcy is a law provided for those who are unable to pay their debts and this law is utilized to provide them with a way of paying their creditors. Since there is no debtor's pri According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product son any more, no one has to worry about going to prison because of not being able to pay. Instead, bankruptcy consolidates the debts and sets up a schedule by which the debts can be ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in paid. In 1800, the first federal bankruptcy law was enacted in the United States. Then in 1803, this law was repealed and it wasn't until 1841 that new bankruptcy laws were passed. lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. The economic panic of 1837 required these new bankruptcy laws. From this date forward, there have been many laws repealed and new ones enacted. The result of these enacted laws hav here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe been to protect the debtor and provide rehabilitation to him so that this time of his loss will not affect him for the rest of his life. In 1933 and 1934 due to the Great Depression d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro , it was necessary to enact a law that was wider in scope to allow companies a chance to reorganize their debt and protect their assets from their creditors. Then in 1978, the Bankru ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ptcy Reform Act was put into law, which expanded on the law of the 1930s in that it provided a stronger reorganization procedure. This law is called Chapter 11 and it replaced Chapte easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi 13 of the bankruptcy law of the 1930s. Chapter 11 made it easier for companies and individuals to file for bankruptcy and be granted protection from their creditors. However, the 1 nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically 978 law did not cover any tax related situations. Thus, in 1980 Bankruptcy Tax Act was enacted, providing for some various taxation rules. In 1982, the bankruptcy court was ruled un and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ constitutional by the US Supreme Court, opening the way for the Bankruptcy Amendment Act of 1984, which took away some powers of the bankruptcy judges. Chapter 12 bankruptcy was crea ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ed in 1986 to include farmers. In October 1994, the Bankruptcy Reform Act of 1994 was signed into law overturning and changing much of the law under the 1978 act. It affected both b ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a usiness and individual bankruptcy laws. It made Chapter 13 more attractive to individuals instead of using Chapter 7 for consolidating and scheduling payment on their debt. It provi dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ded creditors more help in securing debt owed them by bankrupt estates. Economic and social changes have prompted the need for reform on the bankruptcy laws through the years. The p cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ast couple of decades have seen changes in the financial world as well as social upheaval. With credit flooding the nation the past several decades, consumer debt has sky rocketed an tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen the rate of default on credit cards has caused many to seek bankruptcy protection. Medical problems, divorce and job losses have caused most of the Chapter 7 bankruptcies. A record t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel number of bankruptcies were filed in the 1980s and early 1990s. Job losses and business losses accounted for this record number of bankruptcies. Many small businesses (the mom and ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust pops) closed during this period, but also large companies such as Texaco, Continental Airlines, Greyhound and Pan Am also filed for bankruptcy. This large number of bankruptcy filing y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products put the bankruptcy courts in a bind to handle all of them; thus, they utilized the assistance of bankruptcy professionals to speed up the court procedure. These professionals were a . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de pproved by the court to act as examiners and mediators. In 2005, the Bankruptcy Abuse Prevention and Consumer Protection Act went into effect under heavy criticism. It places new re elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip strictions both on individuals and companies as to how their debt will be reorganized to be paid. In effect, it tends to make it harder for everyone to file for bankruptcy protection tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:How to Make Money with Your Own Co-Op Advertising Program How To Make Money From Moving House (Without Actually Moving Anywhere)
|